![]() | Up a level |
Meckiff, Benjamin J, Ramirez-Suastegui, Ciro, Fajardo, Vicente, Chee, Serena J, Kusnadi, Anthony, Simon, Hayley, Eschweiler, Simon, Grifoni, Alba, Pelosi, Emanuela, Weiskopf, Daniela et al (show 5 more authors)
(2020)
Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19.
Cell, 183 (5).
pp. 1340-1353.
Eschweiler, Simon, Ramirez-Suastegui, Ciro, Li, Yingcong, King, Emma, Chudley, Lindsey, Thomas, Jaya, Wood, Oliver, von Witzleben, Adrian, Jeffrey, Danielle, McCann, Katy et al (show 32 more authors)
(2022)
Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs.
NATURE, 605 (7911).
741-+.
Eschweiler, Simon, Clarke, James, Ramirez-Suastegui, Ciro, Panwar, Bharat, Madrigal, Ariel, Chee, Serena J, Karydis, Ioannis, Woo, Edwin, Alzetani, Aiman, Elsheikh, Somaia et al (show 7 more authors)
(2021)
Intratumoral follicular regulatory T cells curtail anti-PD-1 treatment efficacy.
NATURE IMMUNOLOGY, 22 (8).
1052-+.
Eschweiler, Simon, Wang, Alice, Ramirez-Suastegui, Ciro, von Witzleben, Adrian, Li, Yingcong, Chee, Serena J, Simon, Hayley, Mondal, Monalisa, Ellis, Matthew, Thomas, Gareth J et al (show 3 more authors)
(2023)
JAML immunotherapy targets recently activated tumor CD8<SUP>+</SUP> T cells.
CELL REPORTS, 42 (2).
112040-.
Kusnadi, Anthony, Ramirez-Suastegui, Ciro, Fajardo, Vicente, Chee, Serena J, Meckiff, Benjamin J, Simon, Hayley, Pelosi, Emanuela, Seumois, Gregory, Ay, Ferhat, Vijayanand, Pandurangan et al (show 1 more authors)
(2021)
Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8<SUP>+</SUP> T cells.
SCIENCE IMMUNOLOGY, 6 (55).
eabe4782-.